Amila Omeragic

Amila Omeragic, PhD, is a Medical Advisor in Vaccines at GSK, specializing in cardiovascular disease, migraine, infectious diseases, and neurodegenerative disorders. They have a robust background in healthcare, previously serving as a Medical Science Liaison in both Cardiovascular, Renal & Metabolism at Novartis and Neurology at Lundbeck. Amila also contributed to academia as a Guest Lecturer at the University of Toronto, focusing on HIV-1 research and pharmacokinetics, areas in which they have established collaborations with key opinion leaders. Amila earned a PhD in Pharmaceutical Sciences from the University of Toronto and a B.Sc. in Biochemistry from the University of Guelph.